Marston’s PLC (LON:MARS – Get Free Report) insider Hayleigh Lupino purchased 45,736 shares of the firm’s stock in a transaction on Wednesday, December 11th. The stock was bought at an average cost of GBX 43 ($0.54) per share, for a total transaction of £19,666.48 ($24,822.01).
Marston’s Price Performance
Shares of LON MARS opened at GBX 43.55 ($0.55) on Friday. The firm has a market cap of £276.19 million, a P/E ratio of -1,451.67, a PEG ratio of -0.16 and a beta of 1.68. Marston’s PLC has a twelve month low of GBX 25.55 ($0.32) and a twelve month high of GBX 46.65 ($0.59). The company has a quick ratio of 0.23, a current ratio of 0.15 and a debt-to-equity ratio of 269.71. The company has a 50 day moving average of GBX 40.25 and a 200 day moving average of GBX 38.25.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the stock. Shore Capital reissued a “buy” rating on shares of Marston’s in a research report on Wednesday, December 4th. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Marston’s in a research note on Wednesday, September 11th.
About Marston’s
Marston’s PLC operates managed, franchised, tenanted, partnership, and leased pubs in the United Kingdom. It is also involved in the property management; telecommunications; and insurance businesses. The company was formerly known as The Wolverhampton & Dudley Breweries PLC and changed its name to Marston’s PLC in January 2007.
Recommended Stories
- Five stocks we like better than Marston’s
- How to Invest in Biotech Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Golden Cross Stocks: Pattern, Examples and Charts
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Marston's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marston's and related companies with MarketBeat.com's FREE daily email newsletter.